Skip to main content

ABG-WTT Global Life Science Capital Partners GP Ltd

13F filer · CIK 0001832108
Reported Aug 14, 2026
Net seller this quarter
13F portfolio value$8.55MU.S. long equity reported on 13F
Positions20 new · 0 closed
Net flow last quarter-$3.24MBuys minus sells
Top 10 positions weight100.0%Concentration

Holdings

13F · last 4 quarters free
Scroll for earlier quarters
CompanyValue% of portfolio% of companyPOSITION CHANGE qoq %First reported
Q2 2026Reported Aug 14, 20262 positions
CBLLCeribell, Inc.$5.36M62.61%0.72%-37.7%Q4 2024
RPIDRapid Micro Biosystems, Inc.$3.2M37.39%Not reportedNot reportedQ1 2022
Q1 2026Reported May 18, 20262 positions
CBLLCeribell, Inc.$8.1M65.87%1.17%Not reportedQ4 2024
RPIDRapid Micro Biosystems, Inc.$4.2M34.13%Not reportedNot reportedQ1 2022
Q4 2025Reported Feb 17, 20262 positions
CBLLCeribell, Inc.$9.69M64.38%1.18%-59.4%Q4 2024
RPIDRapid Micro Biosystems, Inc.$5.36M35.62%Not reportedNot reportedQ1 2022
Q3 2025Reported Nov 14, 20252 positions
CBLLCeribell, Inc.$12.5M66.94%2.94%Not reportedQ4 2024
RPIDRapid Micro Biosystems, Inc.$6.17M33.06%Not reportedNot reportedQ1 2022
Premium opens every quarter this fund has filed
SpoorBase

Not investment advice. We make every effort to keep the information on SpoorBase accurate, but errors may occur. SpoorBase does not guarantee the accuracy or completeness of any data, and any use of the information is at the user’s sole responsibility. Valuation multiples are calculated by SpoorBase and may contain errors. See Disclosures. © 2026 SpoorBase. All rights reserved.